{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:53:07Z","timestamp":1790401987815,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.placenta.2014.03.011","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T22:17:15Z","timestamp":1396304235000},"page":"425-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["hCG in screening for aneuploidy: A possible role for its glycoforms?"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Brun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Leguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Anselem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guibourdenche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2014.03.011_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mrdd.20157","article-title":"Epidemiology of Down syndrome","volume":"13","author":"Sherman","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.placenta.2014.03.011_bib2","first-page":"1773","article-title":"How to improve the screening and diagnosis of fetal aneuploidy?","volume":"189","author":"Ville","year":"2005","journal-title":"Bull Acad Med"},{"issue":"S19\u2013S26","key":"10.1016\/j.placenta.2014.03.011_bib3","article-title":"Down's syndrome epidemiology and risk estimation","volume":"47","author":"Palomaki","year":"1996","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.placenta.2014.03.011_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1515\/cclm.2011.671","article-title":"Prenatal screening for trisomy 21: recent advances and guidelines","volume":"50","author":"Canick","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.placenta.2014.03.011_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pd.1970070904","article-title":"Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities","volume":"7","author":"Bogart","year":"1987","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2014.03.011_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/07853899409147323","article-title":"First trimester biochemical screening for Down\u2019s syndrome","volume":"26","author":"Wald","year":"1994","journal-title":"Ann Mediaev"},{"key":"10.1016\/j.placenta.2014.03.011_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1749-6632.1991.tb37949.x","article-title":"Biochemistry and endocrinology of the Down's syndrome pregnancy","volume":"626","author":"Chard","year":"1991","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.placenta.2014.03.011_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1210\/jc.2003-030668","article-title":"Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy","volume":"89","author":"Frendo","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.placenta.2014.03.011_bib9","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1210\/en.2007-0589","article-title":"Human placental development is impaired by abnormal human chorionic gonadotropin signaling in trisomy 21 pregnancies","volume":"148","author":"Pidoux","year":"2007","journal-title":"Endocrinologist"},{"key":"10.1016\/j.placenta.2014.03.011_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1258\/0004563053026880","article-title":"First trimester maternal serum screening for Down\u2019s syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy protein-A assays","volume":"42","author":"Spencer","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.placenta.2014.03.011_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pd.2637","article-title":"Screening for fetal aneuploidies at 11 to 13 weeks","volume":"31","author":"Nicolaides","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2014.03.011_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12291-012-0269-9","article-title":"First trimester maternal screening using biochemical markers PAPP-A and free \u03b2-hCG for Down syndrome, Patau syndrome and Edward syndrome","volume":"28","author":"Shiefa","year":"2013","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.placenta.2014.03.011_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/uog.6123","article-title":"Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A","volume":"32","author":"Kagan","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2014.03.011_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/uog.10070","article-title":"First trimester detection of structural abnormalities and the role of aneuploidy markers","volume":"339","author":"Grande","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2014.03.011_bib15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jama.285.8.1044","article-title":"Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis","volume":"285","author":"Smith-Bindman","year":"2001","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.placenta.2014.03.011_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2004.03.090","article-title":"Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities","volume":"191","author":"Nicolaides","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2014.03.011_bib17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/pd.3873","article-title":"Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomy 21, 18 and 13 and Turner syndrome","volume":"32","author":"Karadzov-Orlic","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2014.03.011_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1097-0223(200005)20:5<411::AID-PD822>3.0.CO;2-2","article-title":"Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2014.03.011_bib19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.7863\/jum.2007.26.9.1209","article-title":"Sonographic detection of trisomy 13 in the first and second trimesters of pregnancy","volume":"26","author":"Watson","year":"2007","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.placenta.2014.03.011_bib20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S1701-2163(16)34961-1","article-title":"Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for fetal aneuploidy in singleton pregnancies","volume":"33","author":"Chitayat","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.placenta.2014.03.011_bib21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.placenta.2013.02.011","article-title":"hCG physiology","volume":"34","author":"Cole","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2014.03.011_bib22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/plac.2000.0553","article-title":"Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies","volume":"21","author":"Roberts","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2014.03.011_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2011.10.029","article-title":"Hyperglycosylated hCG, hCG\u03b2 and Hyperglycosylated hCG\u03b2: interchangeable cancer promoters","volume":"349","author":"Cole","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.placenta.2014.03.011_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.507","article-title":"Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay","volume":"23","author":"Talbot","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2014.03.011_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/17530050802558907","article-title":"Human chorionic gonadotropin isoforms and their epitopes: diagnostic utility in pregnancy and cancer","volume":"2","author":"Berger","year":"2008","journal-title":"Expert Point Med Diagn"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:50:42Z","timestamp":1758909042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400414001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0143400414001209"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2014.03.011","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"hCG in screening for aneuploidy: A possible role for its glycoforms?","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2014.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}